Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acura Pharmaceuticals Inc ACUR

Healthcare Drug Manufacturers - Specialty & Generic
Acura Pharmaceuticals, Inc. is a drug delivery company engaged in the research, development, and commercialization of technologies and products to address the safe use of medications. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the... see more

Recent & Breaking News (GREY:ACUR)

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx(TM) LTX-03

GlobeNewswire March 1, 2022

Acura Pharmaceuticals Provides Development Update on LTX-03

GlobeNewswire February 14, 2022

Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results

GlobeNewswire November 15, 2021

Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results

GlobeNewswire August 16, 2021

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx(TM) LTX-03

GlobeNewswire July 26, 2021

Acura Pharmaceuticals Announces Conversion of Debt

GlobeNewswire June 14, 2021

Acura Pharmaceuticals Provides Development Update on LTX-03

GlobeNewswire June 7, 2021

Acura Pharmaceuticals Announces First Quarter Ended March 31, 2021 Financial Results

GlobeNewswire May 17, 2021

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 31, 2021

Acura Pharmaceuticals Announces Third Quarter 2020 Financial Results

GlobeNewswire November 16, 2020

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx(TM) LTX-03

GlobeNewswire October 28, 2020

Acura Pharmaceuticals Announces Second Quarter 2020 Financial Results

GlobeNewswire August 14, 2020

Acura Pharmaceuticals Announces First Quarter 2020 Financial Results

GlobeNewswire June 29, 2020

Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire March 30, 2020

Acura Pharmaceuticals Provides an Update on the Development of LTX-03

GlobeNewswire March 23, 2020

Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results

GlobeNewswire February 28, 2020

Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results

GlobeNewswire February 10, 2020

Acura Pharmaceuticals Provides an Update on the Development of LTX-03

GlobeNewswire January 2, 2020

Acura Pharmaceuticals Announces First Quarter 2019 Financial Results

GlobeNewswire October 1, 2019

Acura Pharmaceuticals Announces Fourth Quarter 2018 and Full Year 2018 Financial Results

GlobeNewswire September 16, 2019